JP2018531045A5 - - Google Patents

Download PDF

Info

Publication number
JP2018531045A5
JP2018531045A5 JP2018536343A JP2018536343A JP2018531045A5 JP 2018531045 A5 JP2018531045 A5 JP 2018531045A5 JP 2018536343 A JP2018536343 A JP 2018536343A JP 2018536343 A JP2018536343 A JP 2018536343A JP 2018531045 A5 JP2018531045 A5 JP 2018531045A5
Authority
JP
Japan
Prior art keywords
antibody polypeptide
seq
amino acid
light chain
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018531045A (ja
JP6916797B2 (ja
JP2018531045A6 (ja
Filing date
Publication date
Priority claimed from GBGB1517550.8A external-priority patent/GB201517550D0/en
Priority claimed from GBGB1519105.9A external-priority patent/GB201519105D0/en
Application filed filed Critical
Priority claimed from PCT/EP2016/073684 external-priority patent/WO2017060247A1/en
Publication of JP2018531045A publication Critical patent/JP2018531045A/ja
Publication of JP2018531045A6 publication Critical patent/JP2018531045A6/ja
Publication of JP2018531045A5 publication Critical patent/JP2018531045A5/ja
Application granted granted Critical
Publication of JP6916797B2 publication Critical patent/JP6916797B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536343A 2015-10-05 2016-10-04 抗体ポリペプチド及びそれらの使用 Active JP6916797B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1517550.8 2015-10-05
GBGB1517550.8A GB201517550D0 (en) 2015-10-05 2015-10-05 Antibody polypeptides and uses thereof
GBGB1519105.9A GB201519105D0 (en) 2015-10-29 2015-10-29 Antibody polypeptides and uses thereof
GB1519105.9 2015-10-29
PCT/EP2016/073684 WO2017060247A1 (en) 2015-10-05 2016-10-04 Humanized anti psa (5a10) antibodies

Publications (4)

Publication Number Publication Date
JP2018531045A JP2018531045A (ja) 2018-10-25
JP2018531045A6 JP2018531045A6 (ja) 2018-12-13
JP2018531045A5 true JP2018531045A5 (cg-RX-API-DMAC10.html) 2019-11-07
JP6916797B2 JP6916797B2 (ja) 2021-08-11

Family

ID=57113327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536343A Active JP6916797B2 (ja) 2015-10-05 2016-10-04 抗体ポリペプチド及びそれらの使用

Country Status (17)

Country Link
US (2) US11332543B2 (cg-RX-API-DMAC10.html)
EP (2) EP3359189B1 (cg-RX-API-DMAC10.html)
JP (1) JP6916797B2 (cg-RX-API-DMAC10.html)
KR (1) KR102783861B1 (cg-RX-API-DMAC10.html)
CN (1) CN108136013B (cg-RX-API-DMAC10.html)
AU (1) AU2016334715B2 (cg-RX-API-DMAC10.html)
CA (1) CA2998818A1 (cg-RX-API-DMAC10.html)
DK (1) DK3359189T3 (cg-RX-API-DMAC10.html)
ES (1) ES2880682T3 (cg-RX-API-DMAC10.html)
IL (1) IL258189B2 (cg-RX-API-DMAC10.html)
LT (1) LT3359189T (cg-RX-API-DMAC10.html)
MX (1) MX2018004071A (cg-RX-API-DMAC10.html)
PL (1) PL3359189T3 (cg-RX-API-DMAC10.html)
PT (1) PT3359189T (cg-RX-API-DMAC10.html)
RU (1) RU2753677C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017060247A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201802019B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016334715B2 (en) * 2015-10-05 2023-02-02 Fredax Ab Humanized anti PSA (5A10) antibodies
SG10201912034UA (en) 2017-02-08 2020-02-27 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
WO2021154746A1 (en) 2020-01-28 2021-08-05 Reflexion Medical, Inc. Joint optimization of radionuclide and external beam radiotherapy

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
FI20002127A0 (fi) * 2000-09-27 2000-09-27 Artic Partners Oy Ab Uusi vasta-aine, immunomääritys ja menetelmä eturauhassyövän havaitsemiseksi
ATE423140T1 (de) 2005-01-05 2009-03-15 F Star Biotech Forsch & Entw Synthetische immunoglobulindomänen mit in regionen des moleküls, die sich von den die komplementarität bestimmenden bereichen unterscheiden, modifizierten bindeeigenschaften
US8663600B2 (en) 2005-02-17 2014-03-04 Diaprost Ab Diagnosis of prostate cancer
AU2009270988A1 (en) * 2008-07-15 2010-01-21 Genentech, Inc. Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
JP2010004895A (ja) * 2009-10-13 2010-01-14 Hiroshima Univ ヒト化ニワトリ抗体の製造方法
DK2771037T3 (en) * 2011-10-28 2016-11-14 Fredax Ab Therapeutics and uses thereof
RU2537263C2 (ru) * 2012-10-22 2014-12-27 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Нижегородский Государственный Университет Им. Н.И. Лобачевского" Способ скрининга и мониторинга онкологических заболеваний и набор для его осуществления (варианты)
GB2520353A (en) * 2013-11-19 2015-05-20 Fredax Ab Antibody polypeptides and uses thereof
CN114740202A (zh) * 2014-03-28 2022-07-12 欧普科诊断有限责任公司 与前列腺癌的诊断有关的组合物和方法
AU2016334715B2 (en) * 2015-10-05 2023-02-02 Fredax Ab Humanized anti PSA (5A10) antibodies

Similar Documents

Publication Publication Date Title
JP2016540503A5 (cg-RX-API-DMAC10.html)
Cheal et al. Pretargeting: a path forward for radioimmunotherapy
JP7828375B2 (ja) 標的分子に対する抗原結合コンストラクト
Kenanova et al. Tailoring antibodies for radionuclide delivery
RU2016124229A (ru) Полипептиды антител и их применения
ES2350477T3 (es) Internalización de anticuerpos anti-cd74 y métodos de uso.
Goldenberg et al. Cancer imaging and therapy with bispecific antibody pretargeting
Navarro-Teulon et al. General overview of radioimmunotherapy of solid tumors
JP5037122B2 (ja) 抗cd74免疫複合体および方法
Chester et al. Engineering antibodies for clinical applications in cancer
Dietrich et al. Improving external beam radiotherapy by combination with internal irradiation
Jhanwar et al. Current status of therapy of solid tumors
Buchsbaum Experimental approaches to increase radiolabeled antibody localization in tumors
TWI908815B (zh) 用於人類疾病之治療的cd38抗體
Accardi et al. Antibodies in single-chain format against tumour-associated antigens: present and future applications
Li et al. The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of 188Re-herceptin
RU2018115734A (ru) Полипептиды антител и их применение
Hauck et al. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia
JP2008506355A (ja) 抗ヒトテネイシンモノクローナル抗体
Lindegren et al. Pretargeted radioimmunotherapy with α-particle emitting radionuclides
US8728477B2 (en) Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof
Vriesendorp et al. Tumour therapy with radiolabelled antibodies: optimisation of therapy
WO2012032043A1 (en) 212 pb imaging
Sergides et al. Radioimmunodetection: technical problems and methods of improvement
ES2541907T3 (es) Secuencias de nucleótidos y proteínas de un anticuerpo dirigido frente a un epítopo común para ferritínas humanas ácidas y básicas, anticuerpos monoclonales o moléculas semejantes a anticuerpo que comprenden estas secuencias y uso de éstos.